Profile
Worth Capital is a venture capital firm based in London, United Kingdom, founded in 2015 by Paul Soanes and Matthew Cushen. The firm is known for its deep understanding of the entrepreneurial journey, with both founders having extensive experience in building and investing in startups. The team is small, comprising three professionals, and focuses on nurturing innovative propositions with the potential to build strong brands.
Worth Capital primarily invests in early-stage companies within the business products, consumer products, and services sectors. They have been instrumental in managing the Start-Up Series Fund, an SEIS and EIS investment fund, in collaboration with Amersham Investment Management. Although the fund is now closed for new investments, it highlights their commitment to supporting startups with strong founder potential. The firm does not currently seek new pitches or investment requests.
Notable investments by Worth Capital include Metacarpal - therapeutic devices, BRAIN FIT - monitoring equipment, Neofin - commercial banking, Paranimo - outpatient services, and Bird Eyewear - accessories. These investments reflect their focus on diverse sectors and their strategic approach to brand-building and growth.
Industry
Worth Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Start-Up Series Fund
|
Venture Capital (VC)
|
Consumer Products
Edtech
E-commerce/Marketplace
Financial Services
Fintech
Food and Beverage
Foodtech
Healthcare Services
Retail
Technology
Internet and Web Services
Marketing and Advertising
Media and Entertainment
Medical Devices
|
Pre-seed
Seed
|
Europe
|
$5-10 m
|
$7 M
|
July 2016
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.